Ebitda Cambiamento Data
AbbVie USD 3.69B 1.68B 2026-03
Actinium Pharmaceuticals USD -5.49M 1.81M 2025-09
Amgen USD 3.86B 1.28B 2026-03
Bioline Rx USD -2.25M 1.7M 2026-03
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Pfizer USD 6.01B 18M 2026-06